Nephrostomy Devices Market Report 2024 - Market Size, Growth Rate, Major Drivers And Key Trends | Becton, Dickinson and Company, Strykar Healthcare, Boston Scientific Corporation

"The new report published by The Business Research Company, titled Nephrostomy Devices Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the nephrostomy devices market size has grown strongly in recent years. It will grow from $1.11 billion in 2023 to $1.20 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The nephrostomy devices market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16493&type=smp

Increase in Kidney Transplants Drives Nephrostomy Device Market Growth
The rise in the incidence of kidney transplants is expected to propel the growth of the nephrostomy device market going forward. A kidney transplant is a surgical procedure in which a healthy kidney from a donor is placed in a person with kidney failure. The increase in kidney transplants is due to the growing incidence of chronic kidney disease and kidney failure and advancements in medical technology and transplant procedures. Nephrostomy devices help in kidney transplants by providing a temporary solution to drain urine directly from the kidneys when there are complications, such as blockages in the urinary tract, ensuring proper kidney function and reducing the risk of infection or damage to the transplanted kidney during the critical post-transplant recovery period. For instance, according to the Health Resources and Services Administration (HRSA), a US-based federal agency within the U.S. Department of Health and Human Services (HHS), in 2022, the number of adult candidates added to the kidney waiting list reached a high of 44,187, surpassing the pre-pandemic peak of 42,932 in 2019. Further, the total number of adult candidates listed for a kidney transplant (including multiple listings for those registered at more than one center) increased slightly to 140,165, compared to 139,011 in 2021. Therefore, the rise in the incidence of kidney transplants is driving the nephrostomy device market.

Advancements in Nephrostomy Devices For Enhancing Efficiency and Patient Outcomes through Pressure Injection Technology
Major companies operating in the nephrostomy devices market are developing innovative products, such as pressure injection in catheters, to improve procedural efficiency and patient outcomes. Pressure injection in a catheter refers to the technique of using controlled pressure to inject fluids or medications through a catheter inserted into the body, typically into the renal system in the case of nephrostomy procedures. For instance, in June 2022, Teleflex Incorporated, a US-based medical device company, launched the Arrow Pressure Injectable Midline. The arrow pressure injectable midline, with its distinctive yellow hubs and labels, simplifies catheter identification to prevent infusion mistakes. Its design maintains a consistent French size, lowering the risk of venous stasis. Streamlined tray configuration and an ergonomic trimmer ensure precise placement during procedures. It incorporates extra safety features, enabling rapid pressure injections of up to 5 mL/second through either lumen, reducing delays in diagnosis and treatment.

The nephrostomy devices market covered in this report is segmented -

1) By Product Type: Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators, Other Products
2) By Application: Kidney Diseases, Urological Cancer And Benign Prostatic Hyperplasia (BPH), Other Applications
3) By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16493&type=discount

Major companies operating in the nephrostomy devices market are Becton, Dickinson and Company, Strykar Healthcare, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Coloplast Corp., B. Braun Medical Inc., Cook Medical, Teleflex Incorporated, Merit Medical Systems, AngioDynamics, Argon Medical Devices, Well Lead Medical Co. Ltd., Amecath, Medi-Globe GmbH, Envaste Limited, Troge Medical GmbH, Rocamed, Suru International Pvt.Ltd., UroMed, Electramed Ltd., Urovision-Urotech, Blueneem Medical Devices Pvt Ltd., Manfred Sauer UK, Surgimedik Healthcare India Pvt Ltd

Contents of the report:
1. Executive Summary
2. Nephrostomy Devices Market Report Structure
3. Nephrostomy Devices Market Trends And Strategies
4. Nephrostomy Devices Market - Macro Economic Scenario
5. Nephrostomy Devices Market Size And Growth
…..
27. Nephrostomy Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.